ALIBERTI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 2.010
AS - Asia 971
EU - Europa 948
AF - Africa 20
OC - Oceania 10
SA - Sud America 7
Totale 3.966
Nazione #
US - Stati Uniti d'America 2.002
SG - Singapore 487
CN - Cina 428
IE - Irlanda 338
FI - Finlandia 273
DE - Germania 93
IT - Italia 79
RU - Federazione Russa 48
GB - Regno Unito 38
SE - Svezia 30
CZ - Repubblica Ceca 21
IN - India 18
NG - Nigeria 18
NL - Olanda 10
AU - Australia 9
CA - Canada 8
HK - Hong Kong 8
JP - Giappone 8
PH - Filippine 7
IL - Israele 6
PT - Portogallo 5
FR - Francia 4
BR - Brasile 3
ID - Indonesia 3
TR - Turchia 3
AR - Argentina 2
BY - Bielorussia 2
KE - Kenya 2
KR - Corea 2
PE - Perù 2
AT - Austria 1
ES - Italia 1
GR - Grecia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
UA - Ucraina 1
Totale 3.966
Città #
Ashburn 471
Boardman 461
Singapore 369
New York 361
Shanghai 349
Dublin 338
Helsinki 273
Los Angeles 100
Seattle 67
Chandler 49
Moscow 41
Phoenix 41
Santa Clara 34
Wilmington 20
Benin City 18
Brno 17
London 17
Pune 14
Hangzhou 11
Lawrence 10
Princeton 10
Shijiazhuang 10
Milan 7
Munich 7
San Mateo 7
Cardiff 6
Naples 6
Sydney 6
Tel Aviv 6
Casal di Principe 5
Falkenstein 5
Gunzenhausen 5
Leawood 5
Wanchai 5
Amsterdam 4
Ann Arbor 4
Cagayan de Oro 4
Ermesinde 4
Olomouc 4
Paris 4
Reggio Calabria 4
Southwark 4
Zhengzhou 4
Andover 3
Cagliari 3
Catania 3
Dolianova 3
Frankfurt am Main 3
Guildford 3
Jember 3
Montecassiano 3
Siena 3
St Petersburg 3
Asagayakita 2
Assendelft 2
Chengdu 2
Cologno Monzese 2
Daiba 2
Etobicoke 2
Groningen 2
Houston 2
Johnson City 2
Kentville 2
Lima 2
Minsk 2
Nairobi 2
Ottawa 2
Qingdao 2
Ragusa 2
San Fernando City 2
San Francisco 2
Sarnthein 2
Seoul 2
Shenzhen 2
São Paulo 2
Turin 2
Verona 2
Ankara 1
Belgrade 1
Brisbane 1
Brooklyn 1
Cambridge 1
Camden 1
Castellammare di Stabia 1
Clifton 1
Concepción del Uruguay 1
Council Bluffs 1
Cupertino 1
Des Moines 1
Dezhou 1
Eygelshoven 1
Ferrara 1
Florence 1
Genoa 1
Grimsby 1
Guangzhou 1
Guiyang 1
Gujrat 1
Handan 1
Harbin 1
Totale 3.288
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 64
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 59
COVID-19 in Immunocompromised Patients: A Systematic Review 46
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 40
Community-acquired pneumonia 38
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 34
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 32
Mapping the human genetic architecture of COVID-19 31
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 28
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 28
A pathway to keep all lifelong learners up to date: The ERS continuing professional development programme 27
Cardiovascular Complications in Community-Acquired Pneumonia 25
COVID-19 in lung transplant recipients: A case series from Milan, Italy 25
How to Identify Causes and Predisposing Factors in Bronchiectasis 25
Cardiovascular side-effects of common antibiotics 24
100 years of respiratory medicine : Pneumonia 24
Respiratory failure in COVID-19: a patient's perspective and clinical cases 23
Post-COVID-19 sequelae 23
O papel da neutropenia no prognóstico do doente oncológico com pneumonia adquirida na comunidade = The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 22
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 22
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 22
Comparison of different conditions for DNA extraction in sputum - a pilot study 21
COVID-19 multidisciplinary high dependency unit: the Milan model 21
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 21
Antibiotics for lung disease and cancer 21
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 21
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 21
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 21
Treatable traits in interstitial lung diseases: a call to action 20
A 13-year-old female with shortness of breath and pleuritic chest pain 20
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 20
Pneumonia: how important are local epidemiology and smoking habits? 19
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 19
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 19
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group 19
What is the best technique to extract bacterial DNA from sputum? 19
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 19
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 18
Multidrug-resistant pathogens in patients with pneumonia coming from the community 18
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 18
Quando ospedalizzare un paziente con polmonite acquisita in comunità 18
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis 18
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 17
A 61-year-old female with chronic cough and purulent sputum 17
Treatment in exacerbations of the upper and lower airways 17
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 17
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 17
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 17
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE 16
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 16
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults 16
Acute exacerbation of COPD: application of evidence-based guidelines 16
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 16
A comprehensive approach to lung function in bronchiectasis 16
Quinine treatment in severe Plasmodium falciparum malaria in children. A Holter monitoring 16
Diagnosis and Initial Investigation of Bronchiectasis 16
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 16
Chlamydia pneumoniae and Mycoplasma pneumoniae 15
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 15
Towards tuberculosis elimination: an action framework for low-incidence countries 15
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 15
Neutrophil elastase in bronchiectasis 15
Vaccinations: What's best? 15
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 15
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 15
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP 15
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 15
Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project 14
Acute exacerbations of COPD : application of evidence-based guidelines 14
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel 14
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 14
Protease-Antiprotease Imbalance in Bronchiectasis 14
Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia 14
Site of care and multidisciplinary approach 14
Hospital-acquired pneumonia 14
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 14
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 14
Vaccinazione antipneumococcica negli adulti: raccomandazioni della Società italiana di medicina respiratoria (SIMeR) e della Società italiana di igiene, medicina preventiva e Sanità pubblica (SItI)=Pneumococcal vaccination in adults: recommendations from the Italian society of respiratory medicine (SIMeR) and the Italian society of hygiene, preventicve medicine and public health (SItI) 14
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 13
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials 13
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 13
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis 13
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)? 13
What is important for people with NTM? An EMBARC-ELF patient survey 13
Mixed Community-acquired Lower Respiratory Tract Infections 13
Acute respiratory failure and severe sepsis in cap : different outcomes? 13
TB elimination : a dream or a reality? Key lessons from the ERS external course in Dubrovnik, Croatia 13
Creatine combined with branched-chain amino acids supplement in speleological practice. A scientific controlled trial 13
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD 13
Antimicrobial Therapy in Community-Acquired Pneumonia. 13
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 13
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 13
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study 13
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline 13
Bronchiectasis: A pulmonary disease with systemic consequences 13
The biology of pulmonary exacerbations in bronchiectasis 13
Blood eosinophils predict inhaled fluticasone response in bronchiectasis 12
Continuous professional development: elevating thoracic oncology education in Europe 12
Get together to increase awareness in bronchiectasisn: a report of the 2nd World Bronchiectasis Conference 12
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 12
Totale 1.905
Categoria #
all - tutte 51.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 9 0 0 0 1 11 5 5 6 2 1 4
2021/202260 0 1 2 4 0 0 0 3 8 20 17 5
2022/2023595 25 8 19 9 16 5 55 14 43 65 322 14
2023/20243.347 221 157 794 191 171 607 220 92 39 143 295 417
2024/2025359 119 23 40 88 89 0 0 0 0 0 0 0
Totale 4.405